The Patent Finder

Summit Corporation PLC

Also on record
Records under this name other than patents Summit Corporation PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Summit Corporation PLC

PatentTitleStatus Expires Confidence
US 8,975,416Antibacterial Compounds
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,314,456Antibacterial compounds
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,842,784Treatment of energy utilization disease
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,987,308Compounds for the Treatment of Clostridium Difficile-Associated Disease
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,481,583Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
Formerly held
Lapsed on the fee record
Ended Jul 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 9, 2025From the USPTO record
US 9,278,091Compounds for the treatment of Clostridium difficile associated disease
Formerly held
Lapsed on the fee record
Ended Mar 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2024From the USPTO record
US 8,518,980Treatment of Duchenne muscular dystrophy
Formerly held
Lapsed on the fee record
Ended Aug 27, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 27, 2021From the USPTO record
US 8,501,713Drug combinations for the treatment of duchenne muscular dystrophy
Formerly held
Lapsed on the fee record
Ended Aug 6, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 6, 2021From the USPTO record
US 9,492,433Pharmaceutical composition for the treatment of Duchenne muscular dystrophy
Formerly held
Lapsed on the fee record
Ended Nov 15, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 15, 2020From the USPTO record
US 8,138,351Treatment of duchenne muscular dystrophy
Formerly held
Lapsed on the fee record
Ended Mar 20, 2020 · From the USPTO record
Lapsed on the fee recordEnded Mar 20, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited